Use of tilmicosin for treatment of pasteurellosis in rabbits

American Journal of Veterinary Research

Volumn 57, Issue 8, 1996, Pages 1180-1184

  McKay, Sharon G ^a   Morck, Douglas W ^a   Merrill, John K ^b   Olson, Merle E ^a   Chan, Siu C ^c   Pap, Kathleen M ^c  

^a UNIVERSITY OF CALGARY   (Canada)

^b ELI LILLY AND COMPANY   (United States)

^c FOOTHILLS HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TILMICOSIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG TISSUE LEVEL; FEMALE; GRAM NEGATIVE INFECTION; MALE; NONHUMAN; PASTEURELLA MULTOCIDA; RABBIT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTI-BACTERIAL AGENTS; FEMALE; LUNG; MACROLIDES; MALE; MICROBIAL SENSITIVITY TESTS; PASTEURELLA INFECTIONS; PASTEURELLA MULTOCIDA; RABBITS; TISSUE DISTRIBUTION; TYLOSIN; UTERUS;

EID: 0029956239     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Flatt RE. Bacterial diseases: Pasteurellosis. In: Weisbroth SH, Flatt RE, Kraus AL, eds. The biology of the laboratory rabbit. New York: Academic Press Inc, 1974;194-205.
2. Webster LT. The epidemiology of a rabbit respiratory infection V. Experimental snuffles. J Exp Med 1924;40:117-127.
3. DiGiacomo RF, Garlinghouse LE Jr, Van Hoosier GL Jr. Natural history of infection with Pasteurella multocida in rabbits. J Am Vet Med Assoc 1983,183:1172-1175.
4. Harkness JE, Wagner JE. Specific diseases and conditions. In: The biology and medicine of rabbits and rodents. 2nd ed. London: Lea & Febiger, 1983;152-154.
5. Percy DH, Black WD. Pharmacokinetics of tetracycline in the domestic rabbit following intravenous or oral administration. Can J Vet Res 1988;52:5-11.
6. Jaslow BW, Ringler DH, Rush HG, et al. Pasteurella associated rhinitis of rabbits: efficacy of penicillin therapy. Lab Anim Sci 1981;31:382-385.
7. Broome RL, Brooks DL. Efficacy of enrofloxacin in the treatment of respiratory pasteurellosis in rabbits. Lab Anim Sci 1991; 41:572-576.
8. Cabanes A, Arboix M, Anton JMG, et al. Pharmacokinetics of enrofloxacin after intravenous and intramuscular injection in rabbits. Am J Vet Res 1992;53:2090-2093.
9. Lu YS, Ringler DH, Park JS. Characterization of Pasteurella multocida isolates from the nares of healthy rabbits and rabbits with pneumonia. Lab Anim Sci 1978;28:691-697.
10. Morck DW, Merrill JK, Thorlakson BE, et al. Prophylactic efficacy of tilmicosin for bovine respiratory tract disease. J Am Vet Med Assoc 1993;202:273-277.
11. Gorham PE, Carroll LH, McAskill JW, et al. Tilmicosin as a single injection treatment for respiratory disease of feedlot cattle. Can Vet J 1990;31:826-829.
12. Laven R, Andrews AH. Long-acting antibiotic formulations in the treatment of calf pneumonia: a comparative evaluation of tilmicosin and oxytetracycline. Vet Rec 1991;129:109-111.
13. Merrill JK, Tonkinson LV. The effectiveness of micotil for the treatment of bovine respiratory disease. Bovine Pract 1989;24: 26-28.
14. Gourlay RN, Thomas LH, Wyld SG, et al. Effect of a new macrolide antibiotic (tilmicosin) on pneumonia experimentally induced in calves by Mycoplasma bovis and Pasteurella haemolytica. Res Vet Sci 1989;47:84-89.
15. Carter GR. Pasteurella, Yersinia and Francisella. In: Carter RG, ed. Diagnostic procedures in veterinary microbiology. Springfield, Ill: Charles C Thomas, 1978;61-68.
16. McAllister HA. Antimicrobial agents and susceptibility tests. In: GR Carter, ed. Diagnostic procedures in veterinary microbiology. Springfield, Ill: Charles C Thomas, 1978;260-272.
17. Baxter P, McKellar Q. Plasma and lung concentrations of oxytetracycline after its administration in rats. Lab Anim Sci 1995; 45:107-109.
18. Kirst HA, Willard KE, Debono M, et al. Structure-activity studies of 20-deoxo-20-amino derivatives of tylosin-related macrolides. J Antibiot 1989;42:1673-1683.